Keyphrases
Dendritic Cells
100%
Cancer Vaccine
100%
CD40
100%
Adenoviral
100%
Tumor Antigen
75%
Adenoviral Vector
50%
Adaptor Molecule
50%
Cell-based
25%
Innate Immune Response
25%
Clinical Trials
25%
Adaptive Immune Response
25%
Genetic Modification
25%
Targeted Delivery
25%
Retargeting
25%
Viral Vectors
25%
Clinical Issues
25%
Cancer Immunotherapy
25%
Bispecific
25%
Clinical Translation
25%
Murine Studies
25%
Targeted Modification
25%
Human Studies
25%
Vector Encoding
25%
Attractive Alternatives
25%
Inter-individual Variability
25%
Two-component
25%
In Vitro Generation
25%
Autologous Dendritic Cells
25%
Personalized Vaccine
25%
Anticancer Immunotherapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Antigen
100%
Tumor Vaccine
100%
Malignant Neoplasm
66%
Immunotherapy
66%
Adenovirus Vector
66%
Receptor
33%
Clinical Trial
33%
Murine
33%
Viral Vector
33%
Dendritic Cell Vaccine
33%
Medicine and Dentistry
Dendritic Cell
100%
Tumor Vaccine
100%
Tumor Antigen
60%
Adenovirus Vector
40%
Cancer Immunotherapy
40%
Innate Immunity
20%
In Vitro
20%
Clinical Trial
20%
Receptor
20%
Ex Vivo
20%
Adaptive Immunity
20%
Dendritic Cell Vaccine
20%
Virus Vector
20%
Immunology and Microbiology
Dendritic Cell
100%
Tumor Vaccine
100%
Tumor Antigen
60%
Cancer Immunotherapy
40%
Adenovirus Vector
40%
Adaptive Immune System
20%
Murine
20%
Innate Immune System
20%
Viral Vector
20%
Dendritic Cell Vaccine
20%